Treatment for advanced lymphoma

Share This Post

Yesterday, the US FDA announced the approval of Seattle Genetics’ antibody-drug conjugate Adcetris (brentuximab vedotin) in combination with chemotherapy for patients with previously treated stage III or IV classic Hodgkin’s lymphoma (cHL). This approval represents an improvement in the initial treatment plan for advanced Hodgkin lymphoma that was introduced into clinical practice more than 40 years ago.

Lymphoma is a type of cancer that begins in the lymphatic system. The immune system helps the body fight infections and diseases. Lymphoma can develop almost anywhere in the body and can spread to nearby lymph nodes. It is divided into two types: Hodgkin lymphoma and non-Hodgkin lymphoma. Most patients with Hodgkin lymphoma belong to the classic type. In this type of lymph node, there are large abnormal lymphocytes (a type of white blood cell). Called Reed-Sternberg cells. Through early intervention, patients with Hodgkin’s lymphoma usually get long-term remission.

In a clinical trial, the potential of Adcetris to treat classic Hodgkin’s lymphoma was validated-the researchers recruited 1,334 treated patients who had previously received an average of 6 courses of 28-day cycles before. Subsequently, they were divided into two groups, one group received Adcetris and chemotherapy (AVD), and the other group received only chemotherapy (ABVD). Studies have shown that patients who receive combination therapy have a 23% lower risk of disease progression, death, or the need to start new treatment compared to patients who only receive chemotherapy.

Adcetris combines antibodies and drugs, allowing antibodies to direct drugs to lymphoma cells called CD30, approved for treatment of relapsed classic Hodgkin lymphoma, classic Hodgkin lymphoma with high risk of relapse or progression after stem cell transplantation, accepted Systemic anaplastic large cell lymphoma that other treatments are not effective, and primary cutaneous anaplastic large cell lymphoma that does not work with other treatments.

Subscribe To Our Newsletter

Get updates and never miss a blog from Cancerfax

More To Explore

Need help? Our team is ready to assist you.

We wish a speedy recovery of your dear and near one.

درمان سرطان در تركيه
Start chat
Need help with cancer treatment?
Scan the code
Welcome to CancerFax !

CancerFax is the most trusted international patient facilitator working with top cancer hospital's in the world like MD Anderson, Dana Farber, Asan, NCC Japan, Sheba, Beijing Cancer Institute and Apollo to bring you best of therapies and drugs.

Let us know what services would you like to avail?

1) Cancer treatment in the USA, Japan, Israel, India, Korea or Singapore?
2) CAR T-Cell therapy treatment
3) Cancer vaccine
4) Online video consultation
5) Proton therapy